Safety and effects of calcifediol 0.266 milligrams soft capsules monthly and cholecalciferol 25000 international units monthly in osteoporotic women undergoing therapy with alendronate: a cross-sectional study.

Autor:	Giampà E; IRCCS Santa Lucia Foundation, Rome, Italy - emiliano.giampa@gmail.com., Celletti E; Department of Rheumatology, SS. Annunziata Hospital, Chieti, Italy., DI Bonito M; Local Health Authority Napoli2 Nord DS35, Bacoli Monte di Procida, Naples, Italy., Ferretti V; Salus Medical Alliance Institute, Genoa, Italy., Gigliotti P; Azienda Sanitaria Provinciale201, Cosenza, Italy., Nuvoli G; Local Health Authority Sassari, Sassari, Italy., Paoletti F; Unit of Internal Medicine and Rheumatology, SF Caracciolo Hospital, Agnone, Isernia, Italy., Piazzini M; Simple Departmental Operational Unit Rheumatology (UOSD), Misericordia Hospital, Grosseto, Italy., Ranieri M; Umberto I Hospital of Tagliacozzo, Tagliacozzo, L'Aquila, Italy., Vinicola V; Unit of Internal Medicine, Osteoporosis Clinic, IRCCS Santa Lucia Foundation, Rome, Italy.
Jazyk:	angličtina
Zdroj:	Minerva endocrinology [Minerva Endocrinol (Torino)] 2024 Jun; Vol. 49 (2), pp. 141-149. Date of Electronic Publication: 2024 Apr 04.
DOI:	10.23736/S2724-6507.24.03920-4
Abstrakt:	Background: The role of vitamin D in human physiology is a topic of great interest for the scientific community in the last decades. The common target for all clinicians is to improve its status in order to prevent several pathological conditions. Methods: The aim of our study was to evaluate the safety and the efficacy of both calcifediol and cholecalciferol in combination with alendronate in osteoporotic women. A homogeneous population of 300 postmenopausal osteoporotic women was selected for this study. 150 women were administered with alendronate 70 mg combined with clacifediol 0.266 mg soft capsules monthly. The other half (other 150 women) were administered with alendronate 70 mg combined with cholecalciferol 25000 IU monthly. First follow-up was after 4 months and second follow-up after 12 months. Results: No case of toxicity was detected throughout the study in any patient. In regards to increase of vitamin D serum level, after four months supplementation calcifediol is 1.29 fold more effective than cholecalciferol while after 12 months of supplementation calcifediol is 2.32 fold more effective compared to cholecalciferol. Conclusions: In our study calcifediol showed to be as safe as cholecalciferol and more effective than cholecalciferol in order to increase vitamin D serum level after four and 12 months of supplementation when supplementation is combined with alendronate 70 mg in osteoporotic women.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu